{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:48Z","timestamp":1788142908736,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00280-017-3453-z","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T04:31:37Z","timestamp":1508387497000},"page":"1261-1264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification"],"prefix":"10.1007","volume":"80","author":[{"given":"Casey L.","family":"McAtee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netta","family":"Schneller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julienne","family":"Brackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Brooke","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"3453_CR1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/jcp.35.10.1086","volume":"35","author":"MB Satti","year":"1982","unstructured":"Satti MB, Weinbren K, Gordon-Smith EC (1982) 6-thioguanine as a cause of toxic veno-occlusive disease of the liver. J Clin Pathol 35:1086\u20131091","journal-title":"J Clin Pathol"},{"key":"3453_CR2","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E et al (2005) A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 90:1396\u20131404","journal-title":"Haematologica"},{"key":"3453_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","volume":"21","author":"KC Myers","year":"2015","unstructured":"Myers KC, Dandoy C, El-Bietar J et al (2015) Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21:379\u2013381. doi:\n                        10.1016\/j.bbmt.2014.09.026","journal-title":"Biol Blood Marrow Transplant"},{"key":"3453_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","volume":"368","author":"A Vora","year":"2006","unstructured":"Vora A, Mitchell CD, Lennard L et al (2006) Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. The Lancet 368:1339\u20131348. doi:\n                        10.1016\/S0140-6736(06)69558-5","journal-title":"The Lancet"},{"key":"3453_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2003.04578.x","volume":"123","author":"S Stoneham","year":"2003","unstructured":"Stoneham S, Lennard L, Coen P et al (2003) Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia. Br J Haematol 123:100\u2013102","journal-title":"Br J Haematol"},{"key":"3453_CR6","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1182\/blood-2009-07-230656","volume":"115","author":"LC Stork","year":"2010","unstructured":"Stork LC, Matloub Y, Broxson E et al (2010) Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children\u2019s Oncology Group CCG-1952 clinical trial. Blood 115:2740\u20132748. doi:\n10.1182\/blood-2009-07-230656","journal-title":"Blood"},{"key":"3453_CR7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE et al (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44:778\u2013783","journal-title":"Transplantation"},{"key":"3453_CR8","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","volume":"17","author":"MD PKS MD","year":"2016","unstructured":"MD MD PKS, MD AA SB, et al (2016) Review consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol 17:e231\u2013e239. doi:\n                        10.1016\/S1470-2045(16)30035-3","journal-title":"Lancet Oncol"},{"key":"3453_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118:255\u2013267","journal-title":"Ann Intern Med"},{"key":"3453_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/pbc.20964","volume":"49","author":"SS Jacobs","year":"2007","unstructured":"Jacobs SS, Stork LC, Bostrom BC et al (2007) Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children\u2019s Oncology Group\/National Cancer Institute pilot trial (CCG-1942). Pediatr Blood Cancer 49:250\u2013255. doi:\n                        10.1002\/pbc.20964","journal-title":"Pediatr Blood Cancer"},{"key":"3453_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/gutjnl-2012-302274","volume":"62","author":"I Oancea","year":"2013","unstructured":"Oancea I, Png CW, Das I et al (2013) A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity. Gut 62:594\u2013605. doi:\n                        10.1136\/gutjnl-2012-302274","journal-title":"Gut"},{"key":"3453_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2002-08-2372","volume":"102","author":"DO Harms","year":"2003","unstructured":"Harms DO (2003) Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood 102:2736\u20132740. doi:\n10.1182\/blood-2002-08-2372","journal-title":"Blood"},{"key":"3453_CR13","doi-asserted-by":"publisher","first-page":"e26519","DOI":"10.1002\/pbc.26519","volume":"33","author":"LN Toksvang","year":"2017","unstructured":"Toksvang LN, De Pietri S, Nielsen SN et al (2017) Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites. Pediatr Blood Cancer 33:e26519\u2013e26518. doi:\n                        10.1002\/pbc.26519","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3453-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T12:23:00Z","timestamp":1510662180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3453-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3453-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}